X. Cynthia

16.9k citations

251 papers · 8.8k indexed · 2 hit papers · h-index 46

Impact in

Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics

Papers in

Oncology 175
- HER2/EGFR in Cancer Research 68
- Cancer Treatment and Pharmacology 56
- Cancer-related Molecular Pathways 18
Cancer Research 92
- Breast Cancer Treatment Studies 59
- Cancer Genomics and Diagnostics 35

Co-authors: Matthew J. Ellis Jeremy Hoog Eric P. Winer Ron Bose Helen Piwnica‐Worms Shunqiang Li Haley Ellis B L Pasloske
Journals: Cancer Research (48 papers)Journal of Clinical Oncology (40 papers)Breast Cancer Research and Treatment (20 papers)Clinical Cancer Research (10 papers)Annals of Oncology (9 papers)
Partner nations: United States Italy United Kingdom

In The Last Decade

X. Cynthia

240 papers receiving 8.7k citations

Hit Papers

align trajectories log scale

CDK4/6 inhibition triggers anti-tumour immunity 2017 · 998 citations

Peers

Countries citing papers authored by X. Cynthia

Since Specialization

Citations

This map shows the geographic impact of X. Cynthia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Cynthia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Cynthia more than expected).

Fields of papers citing papers by X. Cynthia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Cynthia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Cynthia. The network helps show where X. Cynthia may publish in the future.

Co-authors

The 25 scholars most cited alongside X. Cynthia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with X. Cynthia Line = papers co-authored together X. Cynthia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract PO1-19-10: Durvalumab + datopotamab deruxtecan in patients with PD-L1 positive advanced/metastatic triple-negative breast cancer: Arm 8 of the phase 1b/2, open label, platform BEGONIA study Cancer Research ·Peter Schmid, X. Cynthia, F. Rizatdinova, Ross Stewart, Katrin Heider, Yorkin Rasulev, Neelima Denduluri	2024	1
2	Abstract PS12-02: Exploration of ctDNA Dynamics in the PACE Trial: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for HR+/HER2- Metastatic Breast Cancer Cancer Research ·Rinath Jeselsohn, Jingxin Fu, S. M. Gabhane, Reshma Mahtani, X. Cynthia, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy L. Miller, Yara Abdou, Elizabeth Riley, Rubina Qamar, Priyanka Sharma, Sonya Reid, Naomi Y. Ko, Yuan Liu, Harold J. Burstein, Michelle K. DeMeo, Sara M. Tolaney, Erica L. Mayer	2024	1
3	O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer Nature Communications ·W. MURISON, P. Bia, Yan Kai, Frédérique Mauguen, Nyaa Hans Ndah, Zhuqing Li, Muhammad Jameel, Y.L. Leong, Mohga BADRAN, Junfeng Ma, X. Cynthia, Kimberly Lerner, Matthew D. Hall, Jingyang Zhong, Wenge Zhu	2024	15
4	383MO Imlunestrant with or without everolimus or alpelisib, in ER+, HER2- advanced breast cancer (aBC): Results from the phase Ia/b EMBER study Annals of Oncology ·Komal Jhaveri, Cristóbal Concha Palavecino, X. Cynthia, Elgene Lim, Kan Yonemori, Erika Hamilton, 孙旭春, S-A. Im, 冨岡寛美, Sarah Sammons, Manali Bhave, Peter A. Kaufman, C. Saura Manich, Tarek Meniawy, Г. В. Жемкова, Roohi Ismail‐Khan, Yuelin Li, Shawn T. Estrem, Xue De-feng, M. Beeram	2023	9
5	Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis JCO Precision Oncology ·Lorenzo Gerratana, Andrew A. Davis, Ilyass Tabiai, Carolina Reduzzi, Katherine Clifton, Naresh Kumar, Michelle Scaman, Ami N. Shah, T.N. Dragunov, Charles S. Dai, Paolo D’Amico, Firas Wehbe, Arielle J. Medford, Seth A. Wander, William J. Gradishar, Amir Behdad, X. Cynthia, Fabio Puglisi, Aditya Bardia, Massimo Cristofanilli	2023	7
6	Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science–Based Study JMIR Research Protocols ·Ashley J. Housten, 江亮演, Graham A. Colditz, X. Cynthia, Jingxia Liu, 英樹伊藤, Nancy U. Lin, Desheng Huo, S. Bonk, G. Smilasky, Zhao Guangyi, 美芽光澤, Casey Burton, Lindsay L. Peterson	2022	2
7	Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets Cancer Immunology Research ·Aude-Hélène Capietto, Camila Carioni de Ávila, David Clever, Kohara Takeaki, Haley Ellis, X. Cynthia, Roberta Faccio	2021	14
8	Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs Journal of Clinical Psychopharmacology ·Tahir Rahman, John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Philip Miller, X. Cynthia, Richard A. Grucza	2021	27
9	Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1 Cell Reports ·Cuige Zhu, Sun-Joong Kim, Arshag D. Mooradian, Jun Song, Ziqian Li, Koen Suilen, Patrick L. Collins, Keren Wang, Zhanfang Guo, Jeremy Hoog, X. Cynthia, Eugene M. Oltz, Jason M. Held, Jieya Shao	2021	14
10	Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy Nature Cancer ·Jason I. Griffiths, Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia, Meghna S. Trivedi, Kevin Kalinsky, Kari B. Wisinski, Ruth O’Regan, Issam Makhoul, Laura M. Spring, Aditya Bardia, Frederick R. Adler, Adam L. Cohen, Jeffrey T. Chang, Qamar J. Khan, Andrea H. Bild	2021	41
11	ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106. Journal of Clinical Oncology ·X. Cynthia, Vera J. Suman, A. Marilyn Leitch, Souzan Sanati, Kiran Vij, Gary Unzeitig, Jeremy Hoog, Mark A. Watson, Olwen Hahn, J. Michael Guenther, Abigail S. Caudle, Travis Dockter, Larissa A. Korde, Anna Weiss, Kelly K. Hunt, Clifford A. Hudis, Eric P. Winer, Ann H. Partridge, Lisa A. Carey, Matthew J. Ellis, (unknown)	2020	27
12	Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer Cancer Discovery ·Svasti Haricharan, Emre Köse, Purba Singh, Kimberly R. Holloway, Meenakshi Anurag, Mike Wiebner, Hao Dong, Jonathan T. Lei, Vera J. Suman, Kelly K. Hunt, John A. Olson, Jeremy Hoog, Shunqiang Li, Shixia Huang, Dean P. Edwards, Shyam M. Kavuri, Matthew N. Bainbridge, X. Cynthia, Matthew J. Ellis	2017	50
13	A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer Clinical Cancer Research ·X. Cynthia, César Sánchez, Feng Gao, Robert J. Crowder, Michael Naughton, Timothy Pluard, Beatrix Rózsáné Szűcs, Zhanfang Guo, Jeremy Hoog, A. Craig Lockhart, Austin Doyle, Charles Erlichman, Matthew J. Ellis	2016	62
14	A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer Clinical Cancer Research ·X. Cynthia, Jingqin Luo, Michael Naughton, Foluso O. Ademuyiwa, Rama Suresh, Malachi Griffith, Obi L. Griffith, Zachary L. Skidmore, Nicholas C. Spies, Avinash Ramu, Lee Trani, Timothy Pluard, Gayathri Nagaraj, Shana Thomas, Zhanfang Guo, Jeremy Hoog, Jing Han, Elaine R. Mardis, Emilia Capasso, Matthew J. Ellis	2015	77
15	The PI3K Pathway as a Therapeutic Target in Breast Cancer X. Cynthia	2015	10
16	Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer Clinical Cancer Research ·Venkataswarup Tiriveedhi, Syunsuke Nojiri, John M. Herndon, Lijin Li, Mark Sturmoski, Matthew J. Ellis, X. Cynthia, Michael Naughton, A. Craig Lockhart, Feng Gao, Timothy P. Fleming, Peter S. Goedegebuure, Thalachallour Mohanakumar, William E. Gillanders	2014	75
17	Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models Molecular Cancer Therapeutics ·Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, X. Cynthia	2013	41
18	Human Aromatase: Gene Resequencing and Functional Genomics Cancer Research ·X. Cynthia, Araba A. Adjei, Oreste E. Salavaggione, R. E. Lindgren, Linda L. Pelleymounter, Liewei Wang, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben, Alex A. Adjei, Richard M. Weinshilboum	2005	155
19	Large Cell Carcinoma With Calcitonin and Vasoactive Intestinal Polypeptide–Associated Verner-Morrison Syndrome Mayo Clinic Proceedings ·Keith W. Pratz, X. Cynthia, Marie‐Christine Aubry, Terri J. Vrtiska, Charles Erlichman	2005	6
20	Large Cell Carcinoma With Calcitonin and Vasoactive Intestinal Polypeptide–Associated Verner-Morrison Syndrome Mayo Clinic Proceedings ·Keith W. Pratz, X. Cynthia, Marie-Christine Aubry, Terri J. Vrtiska, Charles Erlichman	2005	16

About X. Cynthia

X. Cynthia is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Genetics, having authored 251 papers that have together received 8.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (94 papers), HER2/EGFR in Cancer Research (68 papers), Breast Cancer Treatment Studies (59 papers), Cancer Treatment and Pharmacology (56 papers), Estrogen and related hormone effects (40 papers), Cancer Genomics and Diagnostics (35 papers), PI3K/AKT/mTOR signaling in cancer (21 papers) and Cancer-related Molecular Pathways (18 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (2.3k citations), Pulmonary and Respiratory Medicine (2.8k citations), Genetics (650 citations) and Immunology (983 citations). X. Cynthia has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Matthew J. Ellis, Jeremy Hoog, Eric P. Winer, Ron Bose, Helen Piwnica‐Worms, Shunqiang Li, Haley Ellis, B L Pasloske, Ian E. Krop and Izabela Chmielewska. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact